Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635.

Balducci, C

Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. [electronic resource] - Psychopharmacology Apr 2003 - 28-36 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0033-3158

10.1007/s00213-002-1385-7 doi


Acetylcholine--metabolism
Animals
Attention--drug effects
Basal Nucleus of Meynert--drug effects
Cerebral Cortex--enzymology
Cholinesterase Inhibitors--pharmacology
Donepezil
Dose-Response Relationship, Drug
Excitatory Amino Acid Agonists
Indans--pharmacology
Male
Photic Stimulation
Piperazines--pharmacology
Piperidines--pharmacology
Pyridines--pharmacology
Rats
Receptors, Serotonin--drug effects
Receptors, Serotonin, 5-HT1
Serotonin Antagonists--pharmacology
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid